Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nami Yamashita, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yamashita N, Morimoto Y, Fushimi A, Ahmad R, Bhattacharya A, Daimon T, Haratake N, Inoue Y, Ishikawa S, Yamamoto M, Hata T, Akiyoshi S, Hu Q, Liu T, Withers H, Liu S, Shapiro GI, Yoshizumi T, Long MD, Kufe D. MUC1-C Dictates PBRM1-Mediate Chronic Induction of Interferon Signaling, DNA Damage Resistance and Immunosuppression in Triple-Negative Breast Cancer. Mol Cancer Res. 2022 Nov 29. PMID: 36445328.
    Citations:    Fields:    
  2. Fushimi A, Morimoto Y, Ishikawa S, Yamashita N, Bhattacharya A, Daimon T, Rajabi H, Jin C, Hagiwara M, Yasumizu Y, Luan Z, Suo W, Wong KK, Withers H, Liu S, Long MD, Kufe D. Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer. Mol Cancer Res. 2022 09 02; 20(9):1379-1390. PMID: 35612556; PMCID: PMC9437561.
    Citations:    Fields:    
  3. Yamashita N, Kufe D. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression. Int J Mol Sci. 2022 Jul 26; 23(15). PMID: 35897789; PMCID: PMC9331006.
    Citations:    Fields:    Translation:HumansCells
  4. Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, Frost TC, Ahmad R, Daimon T, Huang L, Hata T, Takahashi H, Yamamoto M, Suzuki Y, DeCaprio JA, Kufe D. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment. Oncogene. 2022 07; 41(27):3511-3523. PMID: 35688945; PMCID: PMC9249628.
    Citations:    Fields:    Translation:HumansCells
  5. Yamashita N, Fushimi A, Morimoto Y, Bhattacharya A, Hagiwara M, Yamamoto M, Hata T, Shapiro GI, Long MD, Liu S, Kufe D. Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. Cancers (Basel). 2022 May 24; 14(11). PMID: 35681561; PMCID: PMC9179855.
    Citations:    
  6. Bhattacharya A, Fushimi A, Yamashita N, Hagiwara M, Morimoto Y, Rajabi H, Long MD, Abdulla M, Ahmad R, Street K, Liu S, Liu T, Kufe D. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells. Mol Cancer Res. 2022 04 01; 20(4):556-567. PMID: 35022313; PMCID: PMC8983489.
    Citations: 2     Fields:    Translation:HumansCells
  7. Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, Hagiwara M, Jin C, Kufe D. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas. Carcinogenesis. 2022 02 11; 43(1):67-76. PMID: 34657147; PMCID: PMC8832436.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  8. Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. Oncoimmunology. 2022; 11(1):2029298. PMID: 35127252; PMCID: PMC8812775.
    Citations: 2     Fields:    Translation:HumansCells
  9. Yamada M, Kubo M, Yamamoto H, Yamashita N, Kai M, Zaguirre K, Kaneshiro K, Shimazaki A, Hayashi S, Kawaji H, Mori M, Oda Y, Nakamura M. Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer. Anticancer Res. 2021 Aug; 41(8):4143-4149. PMID: 34281885.
    Citations:    Fields:    Translation:Humans
  10. Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T. Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. Breast Cancer. 2021 Jul; 28(4):985-986. PMID: 33886078.
    Citations:    Fields:    
  11. Hagiwara M, Fushimi A, Yamashita N, Bhattacharya A, Rajabi H, Long MD, Yasumizu Y, Oya M, Liu S, Kufe D. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells. Oncogene. 2021 07; 40(30):4930-4940. PMID: 34163028.
    Citations: 8     Fields:    Translation:HumansCells
  12. Yamashita N, Long M, Fushimi A, Yamamoto M, Hata T, Hagiwara M, Bhattacharya A, Hu Q, Wong KK, Liu S, Kufe D. MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. J Immunother Cancer. 2021 01; 9(1). PMID: 33495298.
    Citations: 8     Fields:    Translation:HumansCells
  13. Hagiwara M, Yasumizu Y, Yamashita N, Rajabi H, Fushimi A, Long MD, Li W, Bhattacharya A, Ahmad R, Oya M, Liu S, Kufe D. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells. Cancer Res. 2021 02 15; 81(4):1111-1122. PMID: 33323379; PMCID: PMC8026569.
    Citations: 16     Fields:    Translation:HumansCells
  14. Kawaji H, Kubo M, Yamashita N, Yamamoto H, Kai M, Kajihara A, Yamada M, Kurata K, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Mori H, Akiyoshi S, Oki E, Oda Y, Baba E, Mori M, Nakamura M. Comprehensive molecular profiling broadens treatment options for breast cancer patients. Cancer Med. 2021 01; 10(2):529-539. PMID: 33274848.
    Citations: 9     Fields:    Translation:Humans
  15. Li W, Zhang N, Jin C, Long MD, Rajabi H, Yasumizu Y, Fushimi A, Yamashita N, Hagiwara M, Zheng R, Wang J, Kui L, Singh H, Kharbanda S, Hu Q, Liu S, Kufe D. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020 06 18; 5(12). PMID: 32427590.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  16. Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. Breast Cancer. 2020 May; 27(3):322-331. PMID: 32240526.
    Citations: 11     Fields:    Translation:Humans
  17. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 Feb 24; 11(1):1095. PMID: 32094369.
    Citations: 1     Fields:    
  18. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 01 17; 11(1):338. PMID: 31953400; PMCID: PMC6969104.
    Citations: 37     Fields:    Translation:HumansAnimalsCells
  19. Maehara Y, Soejima Y, Yoshizumi T, Kawahara N, Oki E, Saeki H, Akahoshi T, Ikegami T, Yamashita YI, Furuyama T, Sugimachi K, Harada N, Tagawa T, Harimoto N, Itoh S, Sonoda H, Ando K, Nakashima Y, Nagao Y, Yamashita N, Kasagi Y, Yukaya T, Kurihara T, Tsutsumi R, Takamori S, Sasaki S, Ikeda T, Yonemitsu Y, Fukuhara T, Kitao H, Iimori M, Kataoka Y, Wakasa T, Suzuki M, Teraishi K, Yoshida Y, Mori M. The evolution of surgical treatment for gastrointestinal cancers. Int J Clin Oncol. 2019 Nov; 24(11):1333-1349. PMID: 31522313.
    Citations: 2     Fields:    Translation:HumansAnimals
  20. Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, Long MD, Hu Q, Liu S, Fushimi A, Yamashita N, Kui L, Hong D, Yamamoto M, Miyo M, Hiraki M, Maeda T, Suzuki Y, Samur MK, Kufe D. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells. Cancer Res. 2019 11 15; 79(22):5711-5722. PMID: 31519689; PMCID: PMC6881519.
    Citations: 23     Fields:    Translation:HumansCells
  21. Kamitani T, Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiraga N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135]. Eur J Radiol. 2019 05; 114:192. PMID: 30954326.
    Citations:    Fields:    
  22. Ohtani K, Ide T, Hiasa KI, Sakamoto I, Yamashita N, Kubo M, Tsutsui H. Cardioprotective effect of renin-angiotensin inhibitors and ß-blockers in trastuzumab-related cardiotoxicity. Clin Res Cardiol. 2019 Oct; 108(10):1128-1139. PMID: 30859381.
    Citations: 8     Fields:    Translation:Humans
  23. Shibata T, Tokunaga E, Hattori S, Watari K, Murakami Y, Yamashita N, Oki E, Itou J, Toi M, Maehara Y, Kuwano M, Ono M. Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Oncotarget. 2018 Dec 14; 9(98):37216-37228. PMID: 30647855; PMCID: PMC6324687.
    Citations: 14     Fields:    
  24. Kamitani T, Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiragami N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population. Eur J Radiol. 2019 01; 110:130-135. PMID: 30599849.
    Citations: 1     Fields:    Translation:Humans
  25. Takamori S, Takada K, Tagawa T, Toyokawa G, Hirai F, Yamashita N, Okamoto T, Oki E, Yoshizumi T, Oda Y, Maehara Y. Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors. Surg Oncol. 2018 Dec; 27(4):637-641. PMID: 30449485.
    Citations: 5     Fields:    Translation:Humans
  26. Inoue Y, Yamashita N, Ueo H, Tanaka K, Saeki H, Oki E, Tokunaga E, Maehara Y. The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer. Anticancer Res. 2018 04; 38(4):2359-2362. PMID: 29599361.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  27. Yamashita N, Tokunaga E, Iimori M, Inoue Y, Tanaka K, Kitao H, Saeki H, Oki E, Maehara Y. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Clin Breast Cancer. 2018 10; 18(5):e1003-e1009. PMID: 29526677.
    Citations: 38     Fields:    Translation:Humans
  28. Inoue Y, Yamashita N, Kitao H, Tanaka K, Saeki H, Oki E, Oda Y, Tokunaga E, Maehara Y. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clin Breast Cancer. 2018 08; 18(4):e643-e650. PMID: 29275106.
    Citations: 3     Fields:    Translation:HumansCells
  29. Noma S, Kiyohara K, Hirokado R, Yamashita N, Migita Y, Tanaka M, Furukawa S, Ogihara H, Morinaga Y, Igura N, Shimoda M. Increase in hydrophobicity of Bacillus subtilis spores by heat, hydrostatic pressure, and pressurized carbon dioxide treatments. J Biosci Bioeng. 2018 Mar; 125(3):327-332. PMID: 29107628.
    Citations:    Fields:    Translation:Cells
  30. Shoji F, Yamashita N, Inoue Y, Kozuma Y, Toyokawa G, Hirai F, Ito K, Tagawa T, Okamoto T, Maehara Y. Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients. Anticancer Res. 2017 10; 37(10):5871-5876. PMID: 28982914.
    Citations: 1     Fields:    Translation:Humans
  31. Oki E, Okano S, Saeki H, Umemoto Y, Teraishi K, Nakaji Y, Ando K, Zaitsu Y, Yamashita N, Sugiyama M, Nakashima Y, Ohgaki K, Oda Y, Maehara Y. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma. Oncology. 2017; 93(6):387-394. PMID: 28910818.
    Citations: 14     Fields:    Translation:HumansCells
  32. Yamashita N, Tokunaga E, Yamamoto H, Shimizu C, Taketani K, Inoue Y, Saeki H, Oki E, Maehara Y. The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity. Anticancer Res. 2017 09; 37(9):5249-5254. PMID: 28870961.
    Citations:    Fields:    Translation:Humans
  33. Inoue Y, Yamashita N, Tokunaga E, Tanaka K, Ueo H, Saeki H, Oki E, Yamamoto H, Maehara Y. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report. Anticancer Res. 2017 04; 37(4):1917-1921. PMID: 28373460.
    Citations: 1     Fields:    Translation:Humans
  34. Tokunaga E, Yamashita N, Tanaka K, Inoue Y, Akiyoshi S, Saeki H, Oki E, Kitao H, Maehara Y. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women. PLoS One. 2016; 11(12):e0168090. PMID: 27977754; PMCID: PMC5158016.
    Citations: 9     Fields:    Translation:Humans
  35. Sugiyama M, Oki E, Nakaji Y, Tsutsumi S, Ono N, Nakanishi R, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, Yamashita N, Saeki H, Okano S, Kitao H, Morita M, Oda Y, Maehara Y. High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer. Cancer Sci. 2016 Nov; 107(11):1705-1716. PMID: 27589478.
    Citations: 17     Fields:    Translation:HumansCells
  36. Nakaji Y, Oki E, Nakanishi R, Ando K, Sugiyama M, Nakashima Y, Yamashita N, Saeki H, Oda Y, Maehara Y. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. J Cancer Res Clin Oncol. 2017 Jan; 143(1):151-160. PMID: 27672042.
    Citations: 12     Fields:    Translation:Humans
  37. Tanaka K, Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy. Breast Cancer. 2017 May; 24(3):384-392. PMID: 27473079.
    Citations:    Fields:    Translation:Humans
  38. Tanaka K, Tokunaga E, Inoue Y, Yamashita N, Saeki H, Okano S, Kitao H, Oki E, Oda Y, Maehara Y. Impact of Expression of Vimentin and Axl in Breast Cancer. Clin Breast Cancer. 2016 12; 16(6):520-526.e2. PMID: 27506606.
    Citations: 13     Fields:    Translation:HumansCells
  39. Takizawa K, Yamamoto H, Taguchi K, Ohno S, Tokunaga E, Yamashita N, Kubo M, Nakamura M, Oda Y. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast. Hum Pathol. 2016 09; 55:30-8. PMID: 27137988.
    Citations: 3     Fields:    Translation:HumansCells
  40. Tokunaga E, Yamashita N, Kitao H, Tanaka K, Taketani K, Inoue Y, Saeki H, Oki E, Oda Y, Maehara Y. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer. Breast. 2016 Feb; 25:62-8. PMID: 26577950.
    Citations: 3     Fields:    Translation:Humans
  41. Yamashita N, Tokunaga E, Kitao H, Hitchins M, Inoue Y, Tanaka K, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Oda Y, Saeki H, Oki E, Maehara Y. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer. Clin Breast Cancer. 2015 Dec; 15(6):498-504. PMID: 26195437.
    Citations: 22     Fields:    Translation:HumansCells
  42. Tokunaga E, Hisamatsu Y, Tanaka K, Yamashita N, Saeki H, Oki E, Kitao H, Maehara Y. Molecular mechanisms regulating the hormone sensitivity of breast cancer. Cancer Sci. 2014 Nov; 105(11):1377-83. PMID: 25155268; PMCID: PMC4462367.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  43. Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY, Nah GS, Du L, Jacob B, Yamashita N, Lai SK, Tan TZ, Mori S, Tanuichi I, Tergaonkar V, Ito Y, Osato M. Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects. Cell Rep. 2014 Aug 07; 8(3):767-82. PMID: 25066130.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  44. Tokunaga E, Okano S, Nakashima Y, Yamashita N, Tanaka K, Akiyoshi S, Taketani K, Shirouzu M, Yamamoto H, Morita M, Maehara Y. Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature. Int J Clin Exp Pathol. 2014; 7(7):4371-80. PMID: 25120822.
    Citations: 4     Fields:    Translation:HumansCells
  45. Taketani K, Tokunaga E, Yamashita N, Tanaka K, Zaitsu Y, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y. A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis. World J Surg Oncol. 2014 Apr 04; 12:84. PMID: 24708742.
    Citations: 3     Fields:    Translation:Humans
  46. Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Taketani K, Aishima S, Oda Y, Morita M, Maehara Y. Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer. Breast Cancer. 2015 Sep; 22(5):520-8. PMID: 24415069.
    Citations: 16     Fields:    Translation:Humans
  47. Morita M, Saeki H, Ito S, Ikeda K, Yamashita N, Ando K, Hiyoshi Y, Ida S, Tokunaga E, Uchiyama H, Oki E, Ikeda T, Yoshida S, Nakashima T, Maehara Y. Technical improvement of total pharyngo-laryngo-esophagectomy for esophageal cancer and head and neck cancer. Ann Surg Oncol. 2014 May; 21(5):1671-7. PMID: 24390709.
    Citations: 11     Fields:    Translation:Humans
  48. Watanabe M, Uehara Y, Yamashita N, Fujimura Y, Nishio K, Sawada T, Takeda K, Koizumi F, Koh Y. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system. Cytometry A. 2014 Mar; 85(3):206-13. PMID: 24327318.
    Citations: 18     Fields:    Translation:HumansCells
  49. Tanaka K, Tokunaga E, Yamashita N, Taketani K, Akiyoshi S, Morita M, Maehara Y. Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancer. Surg Today. 2014 Sep; 44(9):1678-84. PMID: 24218007.
    Citations: 2     Fields:    Translation:Humans
  50. Taketani K, Tokunaga E, Yamashita N, Tanaka K, Akiyoshi S, Okada S, Ando K, Kimura Y, Saeki H, Oki E, Morita M, Kusumoto T, Maehara Y. Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients. Surg Today. 2014 Oct; 44(10):1841-6. PMID: 24142101.
    Citations: 3     Fields:    Translation:Humans
  51. Tokunaga E, Hisamatsu Y, Taketani K, Yamashita N, Akiyoshi S, Okada S, Tanaka K, Saeki H, Oki E, Aishima S, Oda Y, Morita M, Maehara Y. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer. Cancer Med. 2013 Dec; 2(6):763-73. PMID: 24403250.
    Citations: 7     Fields:    Translation:Humans
  52. Morita M, Saeki H, Ito S, Kimura Y, Yamashita N, Ando K, Hiyoshi Y, Tokunaga E, Oki E, Ikeda T, Yoshida S, Nakashima T, Maehara Y. Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today. 2014 Sep; 44(9):1603-10. PMID: 23989943.
    Citations: 8     Fields:    Translation:Humans
  53. Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y. Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol. 2013 May; 139(5):739-46. PMID: 23354842.
    Citations: 51     Fields:    Translation:HumansCells
  54. Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M, Maehara Y. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer. 2014 May; 21(3):341-9. PMID: 22903204.
    Citations: 29     Fields:    Translation:Humans
  55. Morrison NA, Stephens AA, Osato M, Polly P, Tan TC, Yamashita N, Doecke JD, Pasco J, Fozzard N, Jones G, Ralston SH, Sambrook PN, Prince RL, Nicholson GC. Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. PLoS One. 2012; 7(8):e42617. PMID: 22912713.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  56. Nakanishi R, Kitao H, Fujinaka Y, Yamashita N, Iimori M, Tokunaga E, Yamashita N, Morita M, Kakeji Y, Maehara Y. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Ann Surg Oncol. 2012 Oct; 19(11):3627-35. PMID: 22526901.
    Citations: 11     Fields:    Translation:HumansCells
  57. Okada S, Tokunaga E, Kitao H, Akiyoshi S, Yamashita N, Saeki H, Oki E, Morita M, Kakeji Y, Maehara Y. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer. Ann Surg Oncol. 2012 May; 19(5):1499-507. PMID: 22179631.
    Citations: 6     Fields:    Translation:HumansCells
  58. Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Aishima S, Morita M, Kakeji Y, Maehara Y. Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer. Ann Surg Oncol. 2012 Apr; 19(4):1145-52. PMID: 21984487.
    Citations: 21     Fields:    Translation:Humans
  59. Tsujimoto T, Hirai T, Kitaoka H, Hata M, Nishio K, Okuchi K, Yamashita N, Yoshida M, Fujii H, Fukui H. Secondary aortoduodenal fistula identified by ultrasonography. J Med Ultrason (2001). 2011 Jul; 38(3):161-5. PMID: 27278504.
    Citations:    Fields:    
  60. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H, Higuchi B, Kanehiro H, Nakajima Y. Erratum to: A case of perforated multiple gastric duplication cysts with five-layered appearance on ultrasonography. J Med Ultrason (2001). 2011 Jan; 38(1):53. PMID: 27278340.
    Citations:    Fields:    
  61. Tokunaga E, Okada S, Yamashita N, Akiyoshi S, Kitao H, Morita M, Kakeji Y, Maehara Y. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers. Breast Cancer. 2012 Apr; 19(2):161-9. PMID: 21063923.
    Citations: 5     Fields:    Translation:Humans
  62. Ng CE, Yokomizo T, Yamashita N, Cirovic B, Jin H, Wen Z, Ito Y, Osato M. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells. 2010 Oct; 28(10):1869-81. PMID: 20799333.
    Citations: 42     Fields:    Translation:AnimalsCells
  63. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H, Higuchi B, Kanehiro H, Nagajima Y. A case of perforated multiple gastric duplication cysts with five-layered appearance on ultrasonography. J Med Ultrason (2001). 2011 Jan; 38(1):47-51. PMID: 27278339.
    Citations:    Fields:    
  64. Jacob B, Osato M, Yamashita N, Wang CQ, Taniuchi I, Littman DR, Asou N, Ito Y. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood. 2010 Feb 25; 115(8):1610-20. PMID: 20008790; PMCID: PMC2830765.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  65. Kasagi Y, Yamazaki K, Nakashima A, Yamana T, Yamashita N, Kayashima H, Hoshino Y, Ishida M, Yoshizumi T, Sadanaga N, Fukuda A, Matsuura H, Okadome K. Chondroblastic osteosarcoma arising from the pleura: report of a case. Surg Today. 2009; 39(12):1064-7. PMID: 19997802.
    Citations: 3     Fields:    Translation:Humans
  66. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H. Ultrasonographic findings of renal arteriovenous malformations. J Med Ultrason (2001). 2009 Mar; 36(1):45-7. PMID: 27276909.
    Citations:    Fields:    
  67. Okayama S, Hirai T, Yamashita N, Somekawa S, Iwano M, Uemura S, Kanauchi M, Saito Y. Contrast-enhanced ultrasonography with Sonazoid for evaluation of renal microcirculation. J Med Ultrason (2001). 2008 Dec; 35(4):183-9. PMID: 27278990.
    Citations: 2     Fields:    
  68. Tokunaga M, Shirabe K, Yamashita N, Hiki N, Yamaguchi T. Bowel obstruction due to sciatic hernia. Dig Surg. 2008; 25(3):185-6. PMID: 18577860.
    Citations: 4     Fields:    Translation:Humans
  69. Motoda L, Osato M, Yamashita N, Jacob B, Chen LQ, Yanagida M, Ida H, Wee HJ, Sun AX, Taniuchi I, Littman D, Ito Y. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells. 2007 Dec; 25(12):2976-86. PMID: 17823240.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  70. Sakaguchi H, Tanaka T, Marugami N, Kichikawa K, Horiuchi H, Morioka C, Toyohara M, Moriya K, Nishiofuku M, Mitoro A, Fukui H, Hirai T, Yamashita N, Ouji Y, Ishizaka S, Yoshikawa M. Cystic echinococcosis in immigrant from Peru: first case treated with percutaneous treatment in Japan. Parasitol Int. 2007 Sep; 56(3):207-10. PMID: 17382581.
    Citations: 1     Fields:    Translation:HumansAnimals
  71. Huang L, Osato M, Yanagida M, Yamashita N, Ito Y. The myeloid features of BXH2 leukemias may result from the lack of one copy of the repetitive sequence in the long terminal repeat viral enhancer. Int J Hematol. 2007 Feb; 85(2):170-2. PMID: 17321997.
    Citations:    Fields:    Translation:AnimalsCells
  72. Yamashita N, Osato M, Huang L, Yanagida M, Kogan SC, Iwasaki M, Nakamura T, Shigesada K, Asou N, Ito Y. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. Br J Haematol. 2005 Nov; 131(4):495-507. PMID: 16281942.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  73. Yanagida M, Osato M, Yamashita N, Liqun H, Jacob B, Wu F, Cao X, Nakamura T, Yokomizo T, Takahashi S, Yamamoto M, Shigesada K, Ito Y. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene. 2005 Jun 30; 24(28):4477-85. PMID: 15856017.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  74. Inoue K, Ozaki S, Ito K, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. Runx3 is essential for the target-specific axon pathfinding of trkc-expressing dorsal root ganglion neurons. Blood Cells Mol Dis. 2003 Mar-Apr; 30(2):157-60. PMID: 12732177.
    Citations: 8     Fields:    Translation:AnimalsCells
  75. Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 2002 Oct; 5(10):946-54. PMID: 12352981.
    Citations: 107     Fields:    Translation:AnimalsCells
  76. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002 Apr 05; 109(1):113-24. PMID: 11955451.
    Citations: 338     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yamashita's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (367)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.